Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion type Assertion NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_head.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion description "[In 2013, in the UK in particular, there has been unprecedented publicity in hereditary breast cancer, with Angelina Jolie's decision to have genetic testing for the BRCA1 gene and subsequently undergo risk reducing mastectomy (RRM), and a pre-release of the NICE guidelines on familial breast cancer in January and their final release on 26th June.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_provenance.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion evidence source_evidence_literature NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_provenance.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion SIO_000772 25510853 NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_provenance.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion wasDerivedFrom befree-2016 NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_provenance.
- NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_assertion wasGeneratedBy ECO_0000203 NP1248260.RAMb_SBD6eALCELqU6D_1JoZJiWFY0zTtrFZreTtONDVA130_provenance.